Stelmakh Edward 4
4 · OptimizeRx Corp · Filed Dec 27, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Stelmakh Edward
CFO/COO
Transactions
- Award
Common Stock
2024-12-23+41,408→ 97,295 total - Award
Stock Option
2024-12-23+77,742→ 77,742 totalExercise: $4.83From: 2025-12-23Exp: 2027-12-23→ Common Stock (77,742 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date.